Found 194 hits with Last Name = 'sandmark' and Initial = 'j' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50262998
(CHEMBL477548 | mesyl-2-(3-(2-amino-2-oxoacetyl)-1-...)Show SMILES CC(C)Cc1c(C(=O)C(N)=O)c2c(OCC(=O)NS(C)(=O)=O)cccc2n1Cc1ccccc1 Show InChI InChI=1S/C24H27N3O6S/c1-15(2)12-18-22(23(29)24(25)30)21-17(27(18)13-16-8-5-4-6-9-16)10-7-11-19(21)33-14-20(28)26-34(3,31)32/h4-11,15H,12-14H2,1-3H3,(H2,25,30)(H,26,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Binding affinity to sPLA2X (unknown origin) |
Bioorg Med Chem Lett 24: 5251-5 (2014)
Article DOI: 10.1016/j.bmcl.2014.09.058
BindingDB Entry DOI: 10.7270/Q2668FS8 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534272
(CHEMBL4593409)Show SMILES C[C@H](Cc1cccc(c1)-c1cc(Cc2ccccc2)ccc1C(N)=O)C(O)=O |r| Show InChI InChI=1S/C24H23NO3/c1-16(24(27)28)12-18-8-5-9-20(14-18)22-15-19(10-11-21(22)23(25)26)13-17-6-3-2-4-7-17/h2-11,14-16H,12-13H2,1H3,(H2,25,26)(H,27,28)/t16-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534275
(CHEMBL4451830)Show SMILES CC(Cc1cccc(c1)-c1cc(Cc2ccccc2)ccc1C(N)=O)C(O)=O Show InChI InChI=1S/C24H23NO3/c1-16(24(27)28)12-18-8-5-9-20(14-18)22-15-19(10-11-21(22)23(25)26)13-17-6-3-2-4-7-17/h2-11,14-16H,12-13H2,1H3,(H2,25,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534274
(CHEMBL4457557)Show SMILES NC(=O)c1ccc(Cc2ccccc2)cc1-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C23H21NO3/c24-23(27)20-11-9-18(13-16-5-2-1-3-6-16)15-21(20)19-8-4-7-17(14-19)10-12-22(25)26/h1-9,11,14-15H,10,12-13H2,(H2,24,27)(H,25,26) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
PDB
UniChem
| PDB
Article
PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50055366
((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)Show SMILES CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1 Show InChI InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-2A expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Group XIIB secretory phospholipase A2-like protein
(Homo sapiens) | BDBM50534272
(CHEMBL4593409)Show SMILES C[C@H](Cc1cccc(c1)-c1cc(Cc2ccccc2)ccc1C(N)=O)C(O)=O |r| Show InChI InChI=1S/C24H23NO3/c1-16(24(27)28)12-18-8-5-9-20(14-18)22-15-19(10-11-21(22)23(25)26)13-17-6-3-2-4-7-17/h2-11,14-16H,12-13H2,1H3,(H2,25,26)(H,27,28)/t16-/m1/s1 | KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <14 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2 in human HepG2 cells |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458617
(CHEMBL4215835)Show SMILES CC(CC(O)=O)c1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(7-17(26)27)13-3-2-4-16(24-13)25-14-9-12(29-19(20,21)22)6-5-11(14)8-15(25)18(23)28/h2-6,8-10H,7H2,1H3,(H2,23,28)(H,26,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458617
(CHEMBL4215835)Show SMILES CC(CC(O)=O)c1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(7-17(26)27)13-3-2-4-16(24-13)25-14-9-12(29-19(20,21)22)6-5-11(14)8-15(25)18(23)28/h2-6,8-10H,7H2,1H3,(H2,23,28)(H,26,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458614
(CHEMBL4210991)Show SMILES C[C@@H](CC(O)=O)c1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O |r| Show InChI InChI=1S/C20H17F3N2O4/c1-11(7-18(26)27)12-3-2-4-14(8-12)25-16-10-15(29-20(21,22)23)6-5-13(16)9-17(25)19(24)28/h2-6,8-11H,7H2,1H3,(H2,24,28)(H,26,27)/t11-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534277
(CHEMBL4453126)Show SMILES NC(=O)c1ccc(Cc2ccccc2)cc1-c1cccc(CC(C2CC2)C(O)=O)c1 Show InChI InChI=1S/C26H25NO3/c27-25(28)22-12-9-19(13-17-5-2-1-3-6-17)15-23(22)21-8-4-7-18(14-21)16-24(26(29)30)20-10-11-20/h1-9,12,14-15,20,24H,10-11,13,16H2,(H2,27,28)(H,29,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534278
(CHEMBL4533403)Show SMILES CCC(Cc1cccc(c1)-c1cc(Cc2ccccc2)ccc1C(N)=O)C(O)=O Show InChI InChI=1S/C25H25NO3/c1-2-20(25(28)29)14-18-9-6-10-21(15-18)23-16-19(11-12-22(23)24(26)27)13-17-7-4-3-5-8-17/h3-12,15-16,20H,2,13-14H2,1H3,(H2,26,27)(H,28,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50366784
(CHEMBL4171084)Show SMILES NC(=O)c1cc2ccc(OC(F)(F)F)cc2n1-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C19H15F3N2O4/c20-19(21,22)28-14-6-5-12-9-16(18(23)27)24(15(12)10-14)13-3-1-2-11(8-13)4-7-17(25)26/h1-3,5-6,8-10H,4,7H2,(H2,23,27)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
PDB
UniChem
Similars
| PDB
Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50366784
(CHEMBL4171084)Show SMILES NC(=O)c1cc2ccc(OC(F)(F)F)cc2n1-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C19H15F3N2O4/c20-19(21,22)28-14-6-5-12-9-16(18(23)27)24(15(12)10-14)13-3-1-2-11(8-13)4-7-17(25)26/h1-3,5-6,8-10H,4,7H2,(H2,23,27)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
PDB
UniChem
Similars
| PDB
Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50055366
((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)Show SMILES CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1 Show InChI InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458605
(CHEMBL4217510)Show SMILES NC(=O)c1cc2ccc(OC(F)(F)F)cc2n1-c1cccc(CCC(O)=O)n1 Show InChI InChI=1S/C18H14F3N3O4/c19-18(20,21)28-12-6-4-10-8-14(17(22)27)24(13(10)9-12)15-3-1-2-11(23-15)5-7-16(25)26/h1-4,6,8-9H,5,7H2,(H2,22,27)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458612
(CHEMBL4214052)Show SMILES CC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O4/c1-11(19(27)28)7-12-3-2-4-14(8-12)25-16-10-15(29-20(21,22)23)6-5-13(16)9-17(25)18(24)26/h2-6,8-11H,7H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458612
(CHEMBL4214052)Show SMILES CC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O4/c1-11(19(27)28)7-12-3-2-4-14(8-12)25-16-10-15(29-20(21,22)23)6-5-13(16)9-17(25)18(24)26/h2-6,8-11H,7H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534276
(CHEMBL4555962)Show SMILES C[C@@H](Cc1cccc(c1)-c1cc(Cc2ccccc2)ccc1C(N)=O)C(O)=O |r| Show InChI InChI=1S/C24H23NO3/c1-16(24(27)28)12-18-8-5-9-20(14-18)22-15-19(10-11-21(22)23(25)26)13-17-6-3-2-4-7-17/h2-11,14-16H,12-13H2,1H3,(H2,25,26)(H,27,28)/t16-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458613
(CHEMBL4204172)Show SMILES COC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O5/c1-29-17(19(27)28)8-11-3-2-4-13(7-11)25-15-10-14(30-20(21,22)23)6-5-12(15)9-16(25)18(24)26/h2-7,9-10,17H,8H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458613
(CHEMBL4204172)Show SMILES COC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O5/c1-29-17(19(27)28)8-11-3-2-4-13(7-11)25-15-10-14(30-20(21,22)23)6-5-12(15)9-16(25)18(24)26/h2-7,9-10,17H,8H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50055366
((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)Show SMILES CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1 Show InChI InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50055366
((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)Show SMILES CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1 Show InChI InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458617
(CHEMBL4215835)Show SMILES CC(CC(O)=O)c1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(7-17(26)27)13-3-2-4-16(24-13)25-14-9-12(29-19(20,21)22)6-5-11(14)8-15(25)18(23)28/h2-6,8-10H,7H2,1H3,(H2,23,28)(H,26,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 using human HDL as substrate pretreated for 20 mins followed by substrate addition and measured after 60 min... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50366811
(CHEMBL4176544)Show SMILES NC(=O)c1cc2ccc(cc2n1-c1cccc(CCC(O)=O)c1)C(F)(F)F Show InChI InChI=1S/C19H15F3N2O3/c20-19(21,22)13-6-5-12-9-16(18(23)27)24(15(12)10-13)14-3-1-2-11(8-14)4-7-17(25)26/h1-3,5-6,8-10H,4,7H2,(H2,23,27)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458608
(CHEMBL4205008)Show SMILES CC(Cc1ccnc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)6-11-4-5-24-16(7-11)25-14-9-13(29-19(20,21)22)3-2-12(14)8-15(25)17(23)26/h2-5,7-10H,6H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458608
(CHEMBL4205008)Show SMILES CC(Cc1ccnc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)6-11-4-5-24-16(7-11)25-14-9-13(29-19(20,21)22)3-2-12(14)8-15(25)17(23)26/h2-5,7-10H,6H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50031106
(CHEMBL3337975)Show InChI InChI=1S/C12H15N3OS/c1-6(2)11-4-8(7(3)17-11)9-5-10(12(13)16)15-14-9/h4-6H,1-3H3,(H2,13,16)(H,14,15) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >51 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 mins |
Bioorg Med Chem Lett 24: 5251-5 (2014)
Article DOI: 10.1016/j.bmcl.2014.09.058
BindingDB Entry DOI: 10.7270/Q2668FS8 |
More data for this
Ligand-Target Pair | |
Group XIIB secretory phospholipase A2-like protein
(Homo sapiens) | BDBM50534272
(CHEMBL4593409)Show SMILES C[C@H](Cc1cccc(c1)-c1cc(Cc2ccccc2)ccc1C(N)=O)C(O)=O |r| Show InChI InChI=1S/C24H23NO3/c1-16(24(27)28)12-18-8-5-9-20(14-18)22-15-19(10-11-21(22)23(25)26)13-17-6-3-2-4-7-17/h2-11,14-16H,12-13H2,1H3,(H2,25,26)(H,27,28)/t16-/m1/s1 | KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2 in atherosclerotic plaque from coronary artery disease patient |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458612
(CHEMBL4214052)Show SMILES CC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O4/c1-11(19(27)28)7-12-3-2-4-14(8-12)25-16-10-15(29-20(21,22)23)6-5-13(16)9-17(25)18(24)26/h2-6,8-11H,7H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 57 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458612
(CHEMBL4214052)Show SMILES CC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O4/c1-11(19(27)28)7-12-3-2-4-14(8-12)25-16-10-15(29-20(21,22)23)6-5-13(16)9-17(25)18(24)26/h2-6,8-11H,7H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 57 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458606
(CHEMBL4205511)Show SMILES CC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)7-12-3-2-4-16(24-12)25-14-9-13(29-19(20,21)22)6-5-11(14)8-15(25)17(23)26/h2-6,8-10H,7H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 65 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458606
(CHEMBL4205511)Show SMILES CC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)7-12-3-2-4-16(24-12)25-14-9-13(29-19(20,21)22)6-5-11(14)8-15(25)17(23)26/h2-6,8-10H,7H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 65 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50366983
(CHEMBL4160483)Show SMILES NC(=O)c1cc2ccc(OC(F)F)cc2n1-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C19H16F2N2O4/c20-19(21)27-14-6-5-12-9-16(18(22)26)23(15(12)10-14)13-3-1-2-11(8-13)4-7-17(24)25/h1-3,5-6,8-10,19H,4,7H2,(H2,22,26)(H,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534279
(CHEMBL4468927)Show SMILES NC(=O)c1ccc(Cc2ccccc2)cc1-c1cccc(CC(O)=O)c1 Show InChI InChI=1S/C22H19NO3/c23-22(26)19-10-9-17(11-15-5-2-1-3-6-15)13-20(19)18-8-4-7-16(12-18)14-21(24)25/h1-10,12-13H,11,14H2,(H2,23,26)(H,24,25) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Mus musculus) | BDBM50458617
(CHEMBL4215835)Show SMILES CC(CC(O)=O)c1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(7-17(26)27)13-3-2-4-16(24-13)25-14-9-12(29-19(20,21)22)6-5-11(14)8-15(25)18(23)28/h2-6,8-10H,7H2,1H3,(H2,23,28)(H,26,27) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 75 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of mouse sPLA2-10 |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50366807
(CHEMBL4172222)Show InChI InChI=1S/C30H47N5O15/c1-11(2)5-4-6-16(39)33-20-23(43)21(41)14(47-29(20)50-28-19(32-12(3)37)22(42)18(31)15(10-36)48-28)9-13(38)26-24(44)25(45)27(49-26)35-8-7-17(40)34-30(35)46/h4,6-8,11,13-15,18-29,36,38,41-45H,5,9-10,31H2,1-3H3,(H,32,37)(H,33,39)(H,34,40,46)/b6-4+/t13?,14-,15-,18-,19-,20-,21+,22+,23-,24+,25-,26-,27-,28-,29+/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458606
(CHEMBL4205511)Show SMILES CC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)7-12-3-2-4-16(24-12)25-14-9-13(29-19(20,21)22)6-5-11(14)8-15(25)17(23)26/h2-6,8-10H,7H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458606
(CHEMBL4205511)Show SMILES CC(Cc1cccc(n1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)7-12-3-2-4-16(24-12)25-14-9-13(29-19(20,21)22)6-5-11(14)8-15(25)17(23)26/h2-6,8-10H,7H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50366839
(CHEMBL4175583)Show SMILES NC(=O)c1cc2ccc(OCC(F)(F)F)cc2n1-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C20H17F3N2O4/c21-20(22,23)11-29-15-6-5-13-9-17(19(24)28)25(16(13)10-15)14-3-1-2-12(8-14)4-7-18(26)27/h1-3,5-6,8-10H,4,7,11H2,(H2,24,28)(H,26,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Mus musculus) | BDBM50366784
(CHEMBL4171084)Show SMILES NC(=O)c1cc2ccc(OC(F)(F)F)cc2n1-c1cccc(CCC(O)=O)c1 Show InChI InChI=1S/C19H15F3N2O4/c20-19(21,22)28-14-6-5-12-9-16(18(23)27)24(15(12)10-14)13-3-1-2-11(8-13)4-7-17(25)26/h1-3,5-6,8-10H,4,7H2,(H2,23,27)(H,25,26) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
PDB
UniChem
Similars
| Article
PubMed
| n/a | n/a | 96 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of mouse sPLA2-10 using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substrate additio... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50055366
((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)Show SMILES CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1 Show InChI InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 107 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 mins |
Bioorg Med Chem Lett 24: 5251-5 (2014)
Article DOI: 10.1016/j.bmcl.2014.09.058
BindingDB Entry DOI: 10.7270/Q2668FS8 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50366840
(CHEMBL4174522)Show SMILES NC(=O)c1cc2ccc(cc2n1-c1cccc(CCC(O)=O)c1)C#N Show InChI InChI=1S/C19H15N3O3/c20-11-13-4-6-14-10-17(19(21)25)22(16(14)9-13)15-3-1-2-12(8-15)5-7-18(23)24/h1-4,6,8-10H,5,7H2,(H2,21,25)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50534280
(CHEMBL4591759)Show SMILES NC(=O)c1ccc(Cc2ccccc2)cc1-c1cccc(CCCC(O)=O)c1 Show InChI InChI=1S/C24H23NO3/c25-24(28)21-13-12-19(14-17-6-2-1-3-7-17)16-22(21)20-10-4-8-18(15-20)9-5-11-23(26)27/h1-4,6-8,10,12-13,15-16H,5,9,11,14H2,(H2,25,28)(H,26,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Astrazeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate preincubated for 10 mins foll... |
ACS Med Chem Lett 7: 884-889 (2016)
Article DOI: 10.1021/acsmedchemlett.6b00188
BindingDB Entry DOI: 10.7270/Q23N26W0 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458609
(CHEMBL4213094)Show SMILES NC(=O)c1cc2ccc(OC(F)(F)F)cc2n1-c1cc(CCC(O)=O)ccn1 Show InChI InChI=1S/C18H14F3N3O4/c19-18(20,21)28-12-3-2-11-8-14(17(22)27)24(13(11)9-12)15-7-10(5-6-23-15)1-4-16(25)26/h2-3,5-9H,1,4H2,(H2,22,27)(H,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458614
(CHEMBL4210991)Show SMILES C[C@@H](CC(O)=O)c1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O |r| Show InChI InChI=1S/C20H17F3N2O4/c1-11(7-18(26)27)12-3-2-4-14(8-12)25-16-10-15(29-20(21,22)23)6-5-13(16)9-17(25)19(24)28/h2-6,8-11H,7H2,1H3,(H2,24,28)(H,26,27)/t11-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-10 using human HDL as substrate pretreated for 20 mins followed by substrate addition and measured after 60 min... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Phospholipase A2 group V
(Homo sapiens (Human)) | BDBM50055366
((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)Show SMILES CCc1c(C(=O)C(N)=O)c2c(OCC(O)=O)cccc2n1Cc1ccccc1 Show InChI InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 124 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human sPLA2-5 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate p... |
ACS Med Chem Lett 9: 594-599 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00505
BindingDB Entry DOI: 10.7270/Q2Z60RMJ |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458613
(CHEMBL4204172)Show SMILES COC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O5/c1-29-17(19(27)28)8-11-3-2-4-13(7-11)25-15-10-14(30-20(21,22)23)6-5-12(15)9-16(25)18(24)26/h2-7,9-10,17H,8H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Phospholipase A2, membrane associated
(Homo sapiens (Human)) | BDBM50458613
(CHEMBL4204172)Show SMILES COC(Cc1cccc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C20H17F3N2O5/c1-29-17(19(27)28)8-11-3-2-4-13(7-11)25-15-10-14(30-20(21,22)23)6-5-12(15)9-16(25)18(24)26/h2-7,9-10,17H,8H2,1H3,(H2,24,26)(H,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-2A (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458608
(CHEMBL4205008)Show SMILES CC(Cc1ccnc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)6-11-4-5-24-16(7-11)25-14-9-13(29-19(20,21)22)3-2-12(14)8-15(25)17(23)26/h2-5,7-10H,6H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Group 10 secretory phospholipase A2
(Homo sapiens (Human)) | BDBM50458608
(CHEMBL4205008)Show SMILES CC(Cc1ccnc(c1)-n1c(cc2ccc(OC(F)(F)F)cc12)C(N)=O)C(O)=O Show InChI InChI=1S/C19H16F3N3O4/c1-10(18(27)28)6-11-4-5-24-16(7-11)25-14-9-13(29-19(20,21)22)3-2-12(14)8-15(25)17(23)26/h2-5,7-10H,6H2,1H3,(H2,23,26)(H,27,28) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of sPLA2-10 (unknown origin) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substr... |
ACS Med Chem Lett 9: 600-605 (2018)
Article DOI: 10.1021/acsmedchemlett.7b00507
BindingDB Entry DOI: 10.7270/Q2Z32272 |
More data for this
Ligand-Target Pair | |
Search and Browse
